The ability of AcF1 and AcF3 to activate multiple receptors on macrophages using one single molecule and to induce a potent antitumor M1 macrophage phenotype makes them attractive novel tools for cancer immunotherapy. The gene discussed is BAZ1A; the disease is cancer.